The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.02

Today's change0.00 0.00%
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.02

Today's change0.00 0.00%
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc closed at (U.S.)$1.02.

Over the last five days, shares have gained 3.03% and 4.94% year to date. Shares have underperformed the S&P 500 by 23.78% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $1.02
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+4.94%
  • Volume0
  • Average volume (10-day)70,466
  • Average volume (1-month)68,547
  • Average volume (3-month)114,574
  • 52-week range(U.S.) $0.91 to (U.S.) $1.53
  • Beta0.00
  • Trailing P/E13.47×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.10
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedNov 30, 201611/30/2016Aug 31, 201608/31/2016May 31, 201605/31/2016Feb 29, 201602/29/2016
Revenue12121110
Total other revenue--------
Total revenue12121110
Gross profit3343
Total cost of revenue9987
Total operating expense2141412
Selling / general / administrative53412
Research & development1121
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-130---8
Operating income10-2-2-2
Interest income (expense), net non-operating---1-10
Gain (loss) on sale of assets--------
Other--------
Income before tax9-2-4-2
Income after tax9-2-40
Income tax, total000-2
Net income11-1-21
Total adjustments to net income--------
Net income before extra. items11-1-21
Minority interest1121
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items11-1-21
Inc. avail. to common incl. extra. items11-1-21
Diluted net income11-1-21
Dilution adjustment--------
Diluted weighted average shares78787877
Diluted EPS excluding extraordinary itemsvalue per share0.14-0.02-0.030.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.14-0.02-0.030.01